Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,195.00
+75.00 (1.82%)
Last updated: May 13, 2025
-19.02%
Market Cap 64.14B
Revenue (ttm) 190.44B
Net Income (ttm) -5.36B
Shares Out 15.33M
EPS (ttm) -357.00
PE Ratio n/a
Forward PE n/a
Dividend 75.00 (1.79%)
Ex-Dividend Date Dec 27, 2024
Volume 36,055
Average Volume 118,597
Open 4,120.00
Previous Close 4,120.00
Day's Range 4,120.00 - 4,225.00
52-Week Range 3,070.00 - 6,130.00
Beta 0.71
RSI 43.14
Earnings Date n/a

About Korea Arlico Pharm

Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea. It offers ETC, OTC, medical device, and other products; and active ingredients. The company provides products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, NSAIDS and analgesics, ointment/cream, respiratory system, gastrointestinal, metabolic disease, antihistamines, anti-virus, genitourinary, alopecia, psychoneurotic, CNS, anthelmintics, and hypnotic diseases. Korea Arlico Pharm Co.,Ltd. w... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 112
Stock Exchange KOSDAQ
Ticker Symbol 260660
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.